Understanding of the tumor microenvironment (TME) structure is likely to have a profound and immediate impact on therapeutic interventions as well as the development of signatures for diagnostic and prognostic evaluations. DNA methylation arrays represent one of the most reproducible molecular assays across replicates and studies, but its value of profiling tumorinfiltrating immune lymphocytes (TILs) hasn't been intensively investigated. Here we report a model-based evaluation of tumor TIL levels using DNA methylation profiles. By employing a hybrid method of stability selection and elastic net, we show that methylation array data in ten TCGA cancer types provide a strikingly accurate prediction of immune cell abundance, in particular the levels of T cells, B cells and cytotoxic cells in skin cutaneous melanoma (SKCM).
Introduction
Understanding of the crosstalk between tumor cells and the host immune microenvironment is crucial to the prediction and monitoring of therapy response, and to the discovery of new targets for drug development [1] . In addition to higher mutation and neo-antigen load [2] [3] [4] , the presence of tumor infiltrating lymphocytes (TIL) is believed to be associated with a favorable prognosis and better response to adjuvant treatment. For example, gene expression signatures specific to CD8+ cytotoxic lymphocytes and dendritic cells have been found to be associated with a better overall clinical outcome in cancer [5] . Insights on the roles of these immune cell types in cancer progression and immune evasion, as well as the association between other immune cells and drug responses, offer new opportunities for more effective interventions[1, 6, 7] .
However, there are still considerable technological and analytical barriers to accurately assessing tumor immunity in situ. The major disadvantages of traditional H&E and immunohistochemical (IHC) staining methods are that they are only semi-quantitative and that they suffer from bias and variability from sample slicing. Flow cytometry analysis offers more accurate immune cell measures, but it is labor intensive and requires fresh tissues and cell type specific markers. Over the past decade, efforts has been made to deconvolve the tumor microenvironment (TME) from microarray or RNA-seq profiled gene expression data. CIBERSORT applies a support vector regression of tumor gene expression profiles on a matrix of reference gene expression signatures [8] . TIMER is a resource that employs a constrained linear regression model on expression levels of informative genes [5] . Both of these two methods require reference gene expression profiles from purified immune cells to identify informative signatures and perform the estimation. On the other hand, single sample gene set enrichment analysis (ssGSEA) calculates the expression enrichment score for a predefined marker gene list within a sample [ref] . Gene expression profiles in reference cells are not required in using ssGSEA, which avoids the potential bias introduced by references. Molecular researches have provide plenty of resources for marker genes in various immune cells. Some are summarized in Bindea et. al. [9] , as well as in the latest nCounter PanCancer Immune profiling panel from NanoString [10] . Studies using the above methods have observed associations between tumor immune infiltration and cancer prognosis in multiple cancer types, which offers great promise in their clinical applications [11, 12] . However, significant variations have been observed between estimations using different methods or references. There is still a pressing need to improve the accuracy in quantifying the cell components of TME to facilitate both retrospective and prospective clinical studies.
DNA methylation has an essential role in the epigenetic control of gene expression and disease development. The haploid human genome has approximately 29 million cytosine-Guanine (CpG) sites with different methylation status [13] , which is collectively referred to as the DNA methylome. An increasing number of cancer methylome profiles from tumor and other tissues have been accumulated in the public domain. To date, TCGA has processed >10,000 samples with two types of array platforms, Infinium HumanMethylation27 (27k array, released in 2009) and HumanMethylation450 (450k array, released in 2011) [14] . They measure around 27,000 and 485,000 individual CpG sites respectively. More cancer samples have been now profiled with HumanMethylationEPIC array (contains over 860k sites) and other platform such as bisulfite sequencing. The methylome profiles have been found to provide stable cell differentiation signatures [ref] , and studies have found that it can accurately estimate cell components in blood samples [15] . Recently, the reference-based method CIBERSORT has been employed to estimate the cellular composition of 9 cell types from DNA methylation data [16] .
In addition, methylation assay have much less stringent tissue sample requirement: it requires small amount of DNA and does not require fresh tissues. As such, there is a strong impetus for a comprehensive analysis of tumor methylomes for immune cell type and response deconvolution.
The predictive biomarker panels based on DNA methylation have great translational potential due to its high detection sensitivity and stable signatures.
In this study, we proposed a model-based method to evaluate the level of tumor infiltrated lymphocytes. We took advantage of the tumor immune cell infiltration results from gene expression profiles using ssGSEA and TIMER. By applying a hybrid method of stability selection and random lasso to 10 cancer types in TCGA, we selected CpG sites (methylation panel CpGs) that are important in predicting tumor immune cell scores for each of 24 immune cell types. We found that genes in close proximity of methylation panel CpGs are enriched in immune response related functions. We observed associations between methylation of panel CpG sites and cancer prognosis. Finally, we focused on three cell types: T cells, B cells, cytotoxic cells in skin cancer, which achieved the best prediction accuracy in the TCGA dataset.
We arrived at a simple linear regression model with ten variables (LS10) for each of the three cell types, and validated our models with 30 newly sequenced skin cancer samples with matched DNA methylation array and RNA-seq profiles. Our study provides a facile model for evaluating levels of immune infiltration in skin cancer using DNA methylation data. The cell type and cancer type specific methylation panels will also serve as an important resource for future clinical studies.
MATERIAL AND METHODS

TCGA methylation and gene expression data
We analyzed 10 major cancer types each with at least 300 samples that have matched T cells, B cells, neutrophils, macrophages, and dendritic cells [5] . 2) Single cell gene set enrichment analysis (ssGSEA) estimates the level of infiltration for 24 immune cells, 2 lymphocyte infiltration summary statistics, as well as the activity of tumor antigen presenting machinery. 24 immune cell type specific signature genes were adopted from Bindea et. al. [9] . Two lymphocyte infiltration summary statistics are defined as in Senbabaoglu et. al. [12] : (1) overall immune infiltration score (IIS) is aggregated from both adaptive and innate immune scores; (2) T cell infiltration score (TIS) is aggregated from nine T cell scores. ssGSEA scores were calculated using R bioconductor package GSVA [17] .
Hybrid method to get methylation panel
We utilized an iterative method as shown in Figure 2A to identify marker CpG sites in tumor immune infiltration. In each iteration, ⅔ of all samples were randomly selected as training set, while the rest of samples were kept as test set. Next, 10% features were randomly selected as candidate features for the regression analysis. Then elastic net regression were performed using R package glmnet [18] . This process was iterated 500 times in consideration of execution time and stability of the results. At the end of all iterations, importance score of each CpG were calculated, and the prediction accuracy was summarized. The importance score is defined as the ratio of the counts that a feature is kept by elastic net divided by the counts that this feature is randomly chosen in the feature pre-selection step. Features with importance score greater than 0.9 (methylation panel CpG sites) were documented in the methylation panel in Supplementary table 2. R source code for feature screening and selection is available at https://github.com/xfwang/immu.
Gene ontology analysis
Gene ontology analysis was performed using Gorilla, using all human protein coding genes as background [19] .
Survival analysis
Clinical data for TCGA dataset were downloaded from https://www.cbioportal.org/. We evaluate the association of each individual CpG biomarker in the methylation panels with patient overall survival (OS) and progression-free survival (PFS) based on Kaplan-Meier method and log-rank test. The log-rank test p values were calculated using R package survival [20] The survival plots were generated using R package survminer and ggplot2 [21] .
SKCM EPIC array and RNA-seq data analysis
R package minfi was used to preprocess the 850K methylation data from EPIC array [22] . CpGs with less than 5% missing value were imputed by the median value of the probe. Quantile normalization method was applied to get beta values. RNA-seq data were aligned to hg19 using TopHat2. Reads were counted using htseq-count. Normalized gene expression TPMs were calculated using RSEM. ssGSEA scores were calculated for 30 new SKCM samples the same as TCGA samples.
RESULTS
Global methylation profiles across tumor types
We analyzed 10 major cancer types that have more than 300 samples with both 450K 
Estimate tumor immune landscape using DNA methylation profiles
We applied a supervised learning method to estimate TIL scores and to identify CpG biomarkers that are important in estimating tumor immune landscape (Figure 2A, see methods) . The TIL scores estimated from RNA-seq using ssGSEA were used as the training response of the immune infiltration level. Compared to gene expression, DNA methylation data are ultra-high dimensional, thus standard feature selection methods such as lasso and elastic net cannot be directly applied due to high computational complexity and unstable estimation. To solve this issue, we employed a hybrid method that combine the advantages of stability selection and random lasso. Stability selection method generates multiple bootstrap samples from the original data, and increases the stability of the result by summarizing the results from multiple bootstraps [23] . Random lasso keeps a subset of features for learning in each iteration, thus alleviate the collinearity issue in the data [24] . Our method is based on an iterative process with the following steps: Samples were first randomly split into training and test set in 2:1 ratio. 10% CpG sites were randomly selected as candidate features before the elastic net model fitting. Using elastic net regression, features were further selected because a fraction of coefficients were suppressed to zero due to L1 regularization. The regularization parameter in elastic net was chosen based on a cross-validation process. We next evaluated the prediction accuracy using test set Pearson and Spearman correlations as well as mean squared error. These steps were iterated for 500 times, considering both the computational complexity and the result stability. Finally, we defined an importance score of each CpG, as its ratio of non-zero coefficients in training models where the CpG is a candidate feature. The CpGs were prioritized by their importance scores. Importance score = 1 indicates the feature is an important signature in predicting TIL levels. Whereas importance score = 0 indicates that the feature is not important in predicting TIL levels.
We observed a high concordance between methylation and RNA-seq predicted TIL scores for 24 cell types and 3 summarizing scores using ssGSEA (as defined in [12] , see method, Figure 2B and Supplementary Table 1). We found that methylation data can accurately predict overall 
Important predictive and prognostic methylation biomarkers
We further investigated specific CpG biomarkers in estimating T cells and B cells, focusing on five cancer types (BRCA, HNSC, LUAD, PRAD and SKCM) with a high prediction accuracy.
Top ranking CpGs are methylation markers that obtain a high predictive power of the tumor immune microenvironment. We first investigated top CpGs that are shared by different cancer types. The importance scores of three CpG sites, cg04776231, cg14094409, and cg04776231 are greater than 0.9 for T cell in all five cancer types ( Figure 3A ). These CpGs are in the gene body of PTPN12, DIABLO, and CCDC57. PTPN12 is a member of protein tyrosine phosphatase (PTP) family gene which has been identified as an important prognosis marker in multiple cancer types.
Previous study has observed abnormally low PTPN12 expression in triple negative breast cancer patients, while restoring PTPN12 expression significantly impacted the tumorigenic and metastatic potential of PTPN12 deficient cells [25] . Decreased expression of PTPN12 is also correlated with poor prognosis in hepatocellular carcinoma [26] and non-small cell lung cancer [27] . Diablo (also called smac) is a protein that interacts and antagonizes inhibitors of apoptosis proteins (IAPs) [28] , and it has been identified as a prognosis marker in multiple cancers like colon cancer [29] , small cell lung cancer [30] . In the case of estimating B cell abundance, three CpG sites, cg26568226, cg01445100 and cg15286847, have importance scores greater than 0.9 in our analysis ( Figure 3B ). They are located in the gene body of CYFIP1, BANP, and KLHL36, respectively. Cyfip1 is a component of WAVE regulatory complex that promotes actin assembly.
It was found to be commonly deleted in various human epithelial cancers, and it may serve as an invasion suppressor gene [31] . BANP encodes a protein that binds to matrix attachment regions, but its gene expression level doesn't significantly vary among tissue types according to GTEx results from UCSC genome browser. BANP gene can also generate a circular RNA from its exon 5-11 (circ-BANP). Circ-BANP has been found to be overexpressed in colorectal cancer and lung cancer samples, and was suggested as a prognosis and therapeutic marker for colorectal and lung cancer [32, 33] . KLHL36 is a gene that was much less investigated in cancer cells compared to the other two, and its molecular functions still remain investigated.
In addition, we studied predictive CpG sites that are shared across different TIL cell types. We found the importance score of cg07638500 is greater than 0.9 in estimating B cells, T cells,
cytotoxic cells as well as overall infiltration scores (TIS and IIS) in SKCM (Supplementary Figure 3). cg07638500 is located in the gene body of myosin light chain kinase (MYLK).
Previous study has found that the gene expression level of MYLK is associated with the invasiveness of uveal melanoma cells [34] . The Venn diagrams of overlapping CpGs across cell types for all five cancer types are available in Supplementary Figure 3 . These results on related functions of top methylation markers suggest that methylation array contains important molecular information of the tumor microenvironment that needs to be further investigated. We documented the methylation biomarkers with importance scores greater than 0.9 (methylation panel) for 33 immune infiltration scores across 10 cancer types in Supplementary Table 2. This will serve as an important resource of methylation biomarkers in understanding the tumor microenvironment.
As an important validation, we investigated the prognosis power of CpGs in our methylation panel using Kaplan-Meier curves and log-rank test. Tumor samples in the top 20th percentile of selected probe value were compared with those in the bottom 20th percentile. We found that the association between methylation and patient survival varies by cancer type ( Figure 3C ). Among ten cancer types in our analysis, SKCM showed the strongest association between CpG biomarkers and prognosis. For example, we found that lower methylation values of cg01445100 (BANP) is associated with improved survival (adjusted p-value <0.01) in SKCM as well as HNSC patients ( Figure 3D and 3E) . These results indicate that the investigation of DNA methylation signatures may provide novel insights to the understanding of tumor progression and prognosis.
Biological functions of top methylation probes
We next investigated the biological functions of genes next to methylation probes in our methylation panel. Gene ontology analysis of the genes closest to selected methylation probes reveals enriched processes related to lymphocyte activation, signal transduction, and regulation of cell adhesion in many cancer types (see Supplementary Table 3 for GO results for BRCA, HNSC, HNSC, LUAD, PRAD and SKCM). The top five enriched processes in SKCM are small GTPase mediated signal transduction, lymphocyte activation, cellular component organization and cell surface receptor signaling pathway. The fraction of methylation marker probes in close proximity to immune marker genes [9] varies from 0 to 26% in all cancer types (Supplementary Table 4 ). We compared the predictive power of immune marker gene related CpGs to the predictive power of our methylation panel, and found a lower prediction accuracy using immune marker gene related CpGs (Supplementary Figure 4) . This result suggests that some CpGs that are not in close proximity of immune marker genes also plays an important role in determining the tumor microenvironment.
Regression models for TIL estimation in SKCM
Our analysis of TCGA data shows that methylation profiles achieves the best prediction accuracy in SKCM. Next, we took two approaches to build practical tools for estimating immune cell infiltration scores in SKCM using our methylation panel. In this analysis, all TCGA samples were used as the training set. The first approach is to directly apply elastic net regression models showed high concordance with the estimates produced by other molecular data [35] . Compared to gene expression data, DNA methylation has further appealing features: (1) DNA methylation signature is generally more reliable and presumably more reproducible in routine analysis than gene expression. The addition of methyl group to cytosine is a very stable chemical alternation.
RNA expression value, on the other hand, is complicated by many factors and is more likely to be affected by somatic copy number variations. Additionally, DNA itself is also chemically more stable than RNA. As previously discussed, methods for deconvolving cell content from molecular data fall into two main categories: reference-based and reference-free [36] . The reference-based method is motivated by the gene expression based deconvolution using constrains (e.g., CIBERSORT), which is implemented based on the cell-type-specific gene expression profiles (GEP). The default reference GEP used in CIBEERSORT is called LM22, which contains 547 genes for distinguishing 22 cell types. These genes were selected based on the differential expression analysis from expression profiles of purified cell subsets, and ideally, they should be exclusively expressed in each cell type they are representing. Similarly, a cell-type-specific methylation reference profiles can be constructed by analyzing methylation profiles of purified cell groups, using differential methylation (DM) analysis or analysis for identifying differential methylated Cytotoxic.cells
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